Clinical Trial Update: Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients [NA]

View source ↗

Summary

A clinical trial is evaluating infusion of alloreactive natural killer (NK) cells in patients with acute myeloid leukemia who have minimal residual disease. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Alloreactive NK cell therapy (Natural killer cells)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Acute Myeloid Leukemia, Minimal Residual Disease | NA | Status: RECRUITING